ARGECEA
Aventis Pharma S.a.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79011603 |
| Registration Number | 3085679 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Law Office Assigned | L60 |
| Employee Name | FRIEDMAN, HOWARD DAVID |
Timeline
| 2005-05-06 | Application Filed |
| 2006-01-31 | Published for Opposition |
| 2006-04-25 | Location: PUBLICATION AND ISSUE SECTION |
| 2006-04-25 | Trademark Registered |
| 2015-05-06 | Cancelled |
| 2015-05-06 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AVENTIS PHARMA S.A. |
| Entity Statement | Société anoynme |
| Address | 20, avenue Raymond Aron F-92160 ANTHONY FR |
| Legal Entity Type | |
| Legal Entity State | FR |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical products for treating cancers |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2005-07-14 | 1 REPR M: |
| NEW APPLICATION ENTERED IN TRAM | 2005-07-15 | 2 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2005-12-05 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2005-12-07 | 4 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2005-12-09 | 5 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2005-12-20 | 6 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2006-01-11 | 7 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2006-01-31 | 8 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2006-04-25 | 9 R.PR A:Allowance for Publication |
| CANCELLED SECTION 71 | 2013-09-20 | 10 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2014-05-20 | 11 INTR P: |
| GENERIC MADRID TRANSACTION CREATED | 2015-05-26 | 12 XXCR P: |
| GENERIC MADRID TRANSACTION SENT TO IB | 2015-05-26 | 13 XXSS O:Outgoing Correspondence |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2015-06-19 | 14 INNT P: |
| CORRECTION TRANSACTION RECEIVED FROM IB | 2015-08-28 | 15 CRCV M: |
| CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2015-09-01 | 16 CORN I:Incoming Correspondence |
| DEATH OF INTERNATIONAL REGISTRATION | 2015-11-27 | 17 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2015-11-27 | 18 DENC O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ARGECEA 86117636 4619906 Live/Registered |
SANOFI BIOTECHNOLOGY 2013-11-13 |
 ARGECEA 79011603 3085679 Dead/Cancelled |
AVENTIS PHARMA S.A. 2005-05-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 